Calling All Celularity, Inc. (CELU) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses

NEW YORK, NY / ACCESSWIRE / July 17, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GX Acquisition Corp. ("GXGX"), which merged with Celularity, Inc. ("Celularity" or the "Company") (NASDAQ:CELU) on January 8, 2021. Such investors who continue to holdto the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/celu.

The investigation concerns whether GXGX failed to provide relevant information to its shareholders before the merger.

What's Next?
If you are aware of any facts relating to this investigation or hold Celularity shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/celu. You can also contact Peretz Bronstein or his Law Clerk and Clients Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Why Bronstein, Gewirtz & Grossman:

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ACCESSWIRE

News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.